12.05.2016 MediClin AG  DE0006595101

DGAP-News: MediClin started well in the 2016 financial year


 
DGAP-News: MediClin AG / Key word(s): Quarter Results MediClin started well in the 2016 financial year 12.05.2016 / 12:32 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- MediClin started well in the 2016 financial year. Offenburg, 12 May 2016 - The members of the Management Board of MEDICLIN Aktiengesellschaft (MediClin) are satisfied with the business development of the first three months of the 2016 financial year. In the first quarter of 2016, Group sales of EUR 141.9 mill. were EUR 5.3 mill. or 3.9 % higher compared to the value of the first quarter 2015. The post-acute segment recorded a sales increase by EUR 4.5 mill., while the acute segment posted a EUR 0.6 mill. and the nursing care business area a EUR 0.2 mill. increase. Thus, the positive sales development seen in 2015 continued in the first quarter of the new financial year. Group EBIT amounted to EUR 1.7 mill. and was thus EUR 0.1 mill. higher than the previous year's value. The post-acute segment solely contributed to the earnings improvement. Gross investments amounted to EUR 7.1 mill. in the first quarter of the 2016 financial year (Q1 2015: EUR 6.8 mill.), pertaining mainly to the reconstruction and expansion of clinics. Capital expenditure is thus in line with the annual budget. Cash and cash equivalents as of 31 March 2016 amounted to EUR 25.0 mill. (31.12.2015: EUR 29.5 mill.). The good start into the 2016 financial year indicates that the sales and earnings targets for the Group and the segments can be achieved. The interim report for the period from 1 January 2016 to 31 March 2016 is available under www.mediclin.de. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics, 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post- acute treatment and medical rehabilitation. MediClin has approximately 9,000 employees. MediClin ─ a company of the Asklepios Group --------------------------------------------------------------------------- 12.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News Service --------------------------------------------------------------------------- 463105 12.05.2016


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,820 Halten 133,95
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,85 19,24 0,53 20,30
KBV KCV KUV EV/EBITDA
0,68 1,72 0,18 1,56
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
9,56% 3,52% 2,92% -7,24%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED